Physician profile
Amber Taylor
NPI 1902154149
$20,336.20
in general payments reported to CMS, 2019-2025
13 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,016 · 2021: $3,690 · 2022: $1,520 · 2023: $190 · 2024: $648 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,136.43 | 2019-2025 | Da Vinci Surgical System |
| Allergan, INC. | $1,099.99 | 2020-2022 | |
| Davol INC. | $1,065.16 | 2019-2021 | |
| Endogastric Solutions, INC | $949.76 | 2019 | |
| Atricure, INC. | $329.71 | 2019-2021 | |
| Bolton Medical INC | $157.91 | 2024 | Treo Abdominal Stent-Graft System |
| Ethicon US, LLC | $133.83 | 2024-2025 | Vistaseal, Ethicon, Monocryl |
| Baxter Healthcare | $126.55 | 2024 | Tisseel, Floseal |
| Kls-Martin L.P. | $126.38 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $88.30 | 2024 | Opdivo |
| Conmed Corporation | $68.27 | 2022 | |
| Innocoll Pharmaceuticals Limited | $32.20 | 2022 | |
| W. L. Gore & Associates, INC. | $21.71 | 2023 | Gore Enform Preperitoneal Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.